Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study - PubMed (original) (raw)
Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study
Zhiguang Zhou et al. Diabetes. 2013 Feb.
Abstract
Adult non-insulin requiring diabetes includes latent autoimmune diabetes of adults (LADA), distinguished from type 2 diabetes by the presence of islet autoantibodies. LADA China determined the characteristics of Chinese LADA. This nationwide, multicenter, clinic-based cross-sectional study was conducted in 46 university-affiliated hospitals in 25 Chinese cities. All 4,880 ketosis-free diabetic patients (<1 year postdiagnosis, without insulin therapy for >6 months, aged ≥30 years) had GAD antibody (GADA) and HLA-DQ genotype measured centrally with clinical data collected locally. GADA-positive subjects were classified as LADA. Of the patients, 5.9% were GADA positive with LADA. LADA showed a north-south gradient. Compared with GADA-negative type 2 diabetes, LADA patients were leaner, with lower fasting C-peptide and less metabolic syndrome. Patients with high GADA titers are phenotypically different from those with low GADA titers, while only a higher HDL distinguished the latter from those with type 2 diabetes. HLA diabetes-susceptible haplotypes were more frequent in LADA, even in those with low-titer GADA. HLA diabetes-protective haplotypes were less frequent in LADA. Our study implicates universal immunogenetic effects, with some ethnic differences, in adult-onset autoimmune diabetes. Autoantibody positivity and titer could be important for LADA risk stratification and accurate therapeutic choice in clinical practice.
Figures
FIG. 1.
Flowchart of LADA China Study. OGTT, oral glucose tolerance test.
FIG. 2.
China map for LADA China Study. , cities from the northeastern part of China; , cities from the northern part of China; , cities from northwestern China; , cities from eastern China; , cities from central China; , cities from southern China; and , cities from southwestern China. LADA frequency was higher in northern than southern China after age, sex, and BMI adjustment (P < 0.040). (A high-quality color representation of this figure is available in the online issue.)
FIG. 3.
Bimodal GADA titer (log 10 transformed) in LADA patients. GADA positivity above or below 180 units/mL largely captured the two modes, with high GADA titer (≥180 units/mL) in 26.5% of patients (76 of 287) and a low GADA titer (<180 units/mL) in 73.5% (211 of 287).
Comment in
- LADA: time for a new definition.
Redondo MJ. Redondo MJ. Diabetes. 2013 Feb;62(2):339-40. doi: 10.2337/db12-1171. Diabetes. 2013. PMID: 23349539 Free PMC article. No abstract available.
Similar articles
- Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z; LADA China Study Group. Liu L, et al. Diabetes Care. 2015 Jan;38(1):16-21. doi: 10.2337/dc14-1770. Epub 2014 Oct 21. Diabetes Care. 2015. PMID: 25336751 - Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway.
Sørgjerd EP, Skorpen F, Kvaløy K, Midthjell K, Grill V. Sørgjerd EP, et al. Diabetologia. 2012 May;55(5):1310-8. doi: 10.1007/s00125-012-2463-y. Diabetologia. 2012. PMID: 22297581 - Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.
Huang G, Yin M, Xiang Y, Li X, Shen W, Luo S, Lin J, Xie Z, Zheng P, Zhou Z. Huang G, et al. Diabetes Metab Res Rev. 2016 Sep;32(6):615-22. doi: 10.1002/dmrr.2779. Epub 2016 Mar 3. Diabetes Metab Res Rev. 2016. PMID: 26787598 - [Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].
Calsolari MR, Rosário PW, Reis JS, Silva SC, Purisch S. Calsolari MR, et al. Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. doi: 10.1590/s0004-27302008000200019. Arq Bras Endocrinol Metabol. 2008. PMID: 18438542 Review. Portuguese. - Diabetes-related antibodies in adult diabetic patients.
Falorni A, Brozzetti A. Falorni A, et al. Best Pract Res Clin Endocrinol Metab. 2005 Mar;19(1):119-33. doi: 10.1016/j.beem.2004.11.010. Best Pract Res Clin Endocrinol Metab. 2005. PMID: 15826926 Review.
Cited by
- Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.
Shi X, Huang G, Wang Y, Liu Z, Deng C, Li X, Zheng P, Zhou Z. Shi X, et al. Diabetologia. 2019 Mar;62(3):399-407. doi: 10.1007/s00125-018-4799-4. Epub 2018 Dec 29. Diabetologia. 2019. PMID: 30594957 - Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey.
Li X, Cao C, Tang X, Yan X, Zhou H, Liu J, Ji L, Yang X, Zhou Z. Li X, et al. Front Endocrinol (Lausanne). 2019 Oct 1;10:661. doi: 10.3389/fendo.2019.00661. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31632345 Free PMC article. - Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
Kibirige D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, Lumu W, Jones AG, Hattersley AT, Smeeth L, Nyirenda MJ. Kibirige D, et al. PLoS One. 2022 May 23;17(5):e0268783. doi: 10.1371/journal.pone.0268783. eCollection 2022. PLoS One. 2022. PMID: 35604955 Free PMC article. - Type 1 diabetes in diverse ancestries and the use of genetic risk scores.
Redondo MJ, Gignoux CR, Dabelea D, Hagopian WA, Onengut-Gumuscu S, Oram RA, Rich SS. Redondo MJ, et al. Lancet Diabetes Endocrinol. 2022 Aug;10(8):597-608. doi: 10.1016/S2213-8587(22)00159-0. Epub 2022 Jun 17. Lancet Diabetes Endocrinol. 2022. PMID: 35724677 Free PMC article. Review. - Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes.
Carlsson S. Carlsson S. Front Physiol. 2019 Mar 26;10:320. doi: 10.3389/fphys.2019.00320. eCollection 2019. Front Physiol. 2019. PMID: 30971952 Free PMC article. Review.
References
- Yang W, Lu J, Weng J, et al. China National Diabetes and Metabolic Disorders Study Group Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090–1101 - PubMed
- Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027–2033 - PubMed
- Danaei G, Finucane MM, Lu Y, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011;378:31–40 - PubMed
- Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet 2010;375:2254–2266 - PubMed
- Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia 2010;53:1250–1253 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials